Coya Therapeutics, Inc. (COYA) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $46.82M | +22.1% |
| 2024 | $38.34M | +17.5% |
| 2023 | $32.63M | +449.9% |
| 2022 | $5.93M | +36.7% |
| 2021 | $4.34M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $46.82M | +22.1% |
| 2024 | $38.34M | +17.5% |
| 2023 | $32.63M | +449.9% |
| 2022 | $5.93M | +36.7% |
| 2021 | $4.34M | — |